Abstract | BACKGROUND: METHODS: LOH at the WT1 locus (11p13) as determined by PCR-RFLP for Hinf1 restriction site and was subsequently examined for its association with intratumoral expression of various growth factors i.e. TGF-beta1, IGF-II, IGF-1R and angiogenesis ( VEGF and Intratumoral micro-vessel density) in breast carcinoma. RESULTS: Six of 22 (27.2%) genetically heterozygous of infiltrating breast carcinoma and 1 of 4 DCIS cases showed loss of one allele at WT1 locus. Histologically, the tumors with LOH at WT1 were Intraductal carcinoma (IDC) and were of grade II and III. There was no correlation in the appearance of LOH at WT1 locus with age, tumor stage, menopausal status, chemotherapy status and lymph node metastasis. The expression of factor IGF-II and its receptor, IGF-1R was significantly higher in carcinoma having LOH at WT1 locus. A positive correlation was observed between the TGF-beta1, VEGF expression and IMD scores in infiltrating carcinoma. CONCLUSIONS: The current study indicates that the high frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in high-graded breast tumors is associated with aggressiveness of the tumor.
|
Authors | S Gupta, K Joshi, J D Wig, S K Arora |
Journal | Indian journal of cancer
(Indian J Cancer)
2009 Oct-Dec
Vol. 46
Issue 4
Pg. 303-10
ISSN: 1998-4774 [Electronic] India |
PMID | 19749460
(Publication Type: Journal Article)
|
Chemical References |
- Transforming Growth Factor beta1
- Vascular Endothelial Growth Factor A
- Insulin-Like Growth Factor II
- Receptor, IGF Type 1
|
Topics |
- Breast Neoplasms
(genetics, pathology)
- Carcinoma in Situ
(genetics, pathology)
- Carcinoma, Ductal, Breast
(genetics, pathology)
- Genes, Wilms Tumor
- Humans
- Insulin-Like Growth Factor II
(biosynthesis)
- Loss of Heterozygosity
- Polymerase Chain Reaction
- Polymorphism, Restriction Fragment Length
- Receptor, IGF Type 1
(biosynthesis)
- Transforming Growth Factor beta1
(biosynthesis)
- Vascular Endothelial Growth Factor A
(biosynthesis)
|